Regulatory Open Forum

 View Only
  • 1.  Confidential nonclinical data submission to NMPA (China)

    This message was posted by a user wishing to remain anonymous
    Posted 17-Sep-2020 08:54
    This message was posted by a user wishing to remain anonymous

    Hello All,

    Does anyone know if a DMF can be used to submit proprietary nonclinical data to NMPA to support another sponsor's drug application in China?  I know NMPA accepts DMFs for APIs, packaging materials, excipients and medical devices but have found no information on the acceptability of submitting other types of proprietary information in a DMF to the Chinese regulatory authority.  Is there a  Chinese equivalent to the U.S. Type V DMF?  

    Or, if a DMF is not viable for this purpose, is there another way to submit proprietary nonclinical data to NMPA?

    Any feedback would be greatly appreciated!

    Thank you


  • 2.  RE: Confidential nonclinical data submission to NMPA (China)

    Posted 04-Mar-2021 03:06
    Dear Anonymous,

    Did you receive appropriate and helpful responses by the time?
    If you want to discuss this further, you can contact me directly.

    Best regards,
    Markus

    ------------------------------
    Markus Roepke
    Business Development D/A/CH
    Cisema GmbH
    Munich Area
    Germany
    roepke@cisema.de
    ------------------------------